Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Ritlecitinib is safe and may effectively treat alopecia areata.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Ritlecitinib works well and is safe for treating alopecia areata.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.